The document provides an analysis of the performance and valuation multiples of healthcare services, pharmaceuticals, and life sciences sectors over a three-month period, highlighting that the S&P healthcare services index increased by 12.0%, while the pharmaceuticals and life sciences index rose by 6.9%. Key performing sectors include emergency services and infection prevention devices, with distinct best and worst performers noted in each category. Additionally, it outlines median revenue and EBITDA multiples for various sectors, identifying consumer directed health & wellness and biotechnology as some of the highest valued sectors.
Related topics: